Broekman, K.E.
Jalving, M.
van Tinteren, H.
Sessa, C.
Reyners, A.K.L.
This article is maintained by: Elsevier
Article Title: Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer – ESMO-MCBS scores
Journal Title: Cancer Treatment Reviews
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ctrv.2018.06.008
Content Type: article
Copyright: © 2018 The Authors. Published by Elsevier Ltd.